NM_000535.7:c.2007-2A>C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000535.7(PMS2):c.2007-2A>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000015 in 1,329,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000535.7 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | NM_000535.7 | MANE Select | c.2007-2A>C | splice_acceptor intron | N/A | NP_000526.2 | |||
| PMS2 | NM_001406866.1 | c.2193-2A>C | splice_acceptor intron | N/A | NP_001393795.1 | ||||
| PMS2 | NM_001322014.2 | c.2007-2A>C | splice_acceptor intron | N/A | NP_001308943.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | ENST00000265849.12 | TSL:1 MANE Select | c.2007-2A>C | splice_acceptor intron | N/A | ENSP00000265849.7 | |||
| PMS2 | ENST00000382321.5 | TSL:1 | c.804-2A>C | splice_acceptor intron | N/A | ENSP00000371758.4 | |||
| PMS2 | ENST00000406569.8 | TSL:1 | n.1678+4094A>C | intron | N/A | ENSP00000514464.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD2 exomes AF: 0.00000631 AC: 1AN: 158418 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000150 AC: 2AN: 1329870Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 661676 show subpopulations
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Observed in a patient who underwent hereditary cancer multigene panel testing (PMID: 24763289); This variant is associated with the following publications: (PMID: 26318770, 24763289, 30013564, 32642664, 37534630, 31992580, 11292842, 18619468, Fukui2011[Chapter])
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in activation of a cryptic splice site and introduces a premature termination codon (Invitae). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 142251). Disruption of this splice site has been observed in individuals with constitutional mismatch repair deficiency (CMMRD) syndrome or clinical features of PMS2-related conditions (PMID: 24763289, 26318770). The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This sequence change affects an acceptor splice site in intron 11 of the PMS2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product.
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.2007-2A>C intronic pathogenic mutation results from an A to C substitution two nucleotides upstream from coding exon 12 in the PMS2 gene. Another alteration impacting the same acceptor site (c.2007-2A>G) has been detected in the homozygous state in multiple individuals diagnosed with constitutional mismatch repair deficiency (Lavoine N et al. J Med Genet, 2015 Nov;52:770-8). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site; however, direct evidence is insufficient at this time (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation.
Lynch syndrome 4 Pathogenic:1
This variant is considered pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 26318770, 30013564, 32642664].
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at